Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-PRLR antibody-drug conjugates (ADC) and uses thereof

Anti-PRLR antibody-drug conjugates (ADC) and uses thereof

US Patent 10112999 · Granted Oct 30, 2018

Estimated economic value: $245,181,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

EGFR and C-met fibronectin type III domain binding molecules2025
Anti-c-Met antibody drug conjugates2023
EGFR and c-Met fibronectin type III domain binding molecules2021
Cysteine engineered fibronectin type III domain binding molecules2020
Anti-cMet antibody drug conjugates and methods for their use2020
Anti-cMet antibody drug conjugates and methods for their use2019
Anti-cMet antibody drug conjugates and methods for their use2019
Prolactin receptor binding proteins and uses thereof2019
Prolactin receptor binding proteins and uses thereof2019
Anti-EGFR antibodies and antibody drug conjugates2018
Anti-EGFR antibodies and antibody drug conjugates2017
EGFR and C-Met fibronectin type III domain binding molecules2017